Patents by Inventor Ahmet Tutuncu

Ahmet Tutuncu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210401740
    Abstract: A method is provided for improving lung function in COPD by administering a muscarinic antagonist with a high efficiency nebulizer.
    Type: Application
    Filed: March 5, 2021
    Publication date: December 30, 2021
    Applicant: Sunovion Respiratory Development Inc.
    Inventors: William GERHART, Ahmet TUTUNCU
  • Patent number: 10940110
    Abstract: A method is provided for improving lung function in COPD by administering a muscarinic antagonist with a high efficiency nebulizer.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: March 9, 2021
    Assignee: SUNOVION RESPIRATORY DEVELOPMENT INC.
    Inventors: William Gerhart, Ahmet Tutuncu
  • Patent number: 10835512
    Abstract: Compositions and methods for the treatment of respiratory syncytial virus infections are provided.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: November 17, 2020
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Manfred Keller, Ahmet Tutuncu
  • Publication number: 20200197362
    Abstract: The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.
    Type: Application
    Filed: January 7, 2020
    Publication date: June 25, 2020
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu, Robert Craig Armstrong
  • Publication number: 20200155452
    Abstract: The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
    Type: Application
    Filed: September 19, 2019
    Publication date: May 21, 2020
    Applicant: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu
  • Patent number: 10583113
    Abstract: The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: March 10, 2020
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu, Robert Craig Armstrong
  • Patent number: 10561635
    Abstract: The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: February 18, 2020
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu, Robert Craig Armstrong
  • Publication number: 20190388385
    Abstract: Methods for the treatment of systemic mast cell related disorders treatable with mast cell stabilizers, including mast well related disorders, are provided.
    Type: Application
    Filed: July 10, 2019
    Publication date: December 26, 2019
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu
  • Publication number: 20190388386
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: July 10, 2019
    Publication date: December 26, 2019
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Patent number: 10463613
    Abstract: The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: November 5, 2019
    Assignee: Respivant Sciences GmbH
    Inventors: Pravin Soni, William Gerhart, Ahmet Tutuncu
  • Publication number: 20190328700
    Abstract: Compositions and methods for the treatment of respiratory syncytial virus infections are provided.
    Type: Application
    Filed: July 10, 2019
    Publication date: October 31, 2019
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Publication number: 20190307721
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: May 7, 2019
    Publication date: October 10, 2019
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Patent number: 10398673
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: September 3, 2019
    Assignee: Respivant Services GmbH
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Patent number: 10391078
    Abstract: Methods for the treatment of systemic mast cell related disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: August 27, 2019
    Assignee: Respivant Sciences GmbH
    Inventors: William Gerhart, Pravin Soni, Ahmet Tutuncu
  • Publication number: 20190254967
    Abstract: A method is provided for improving lung function in COPD by administering a muscarinic antagonist with a high efficiency nebulizer.
    Type: Application
    Filed: December 12, 2018
    Publication date: August 22, 2019
    Inventors: William Gerhart, Ahmet Tutuncu
  • Publication number: 20190224161
    Abstract: The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 25, 2019
    Inventors: William GERHART, Ahmet TUTUNCU, Robert Craig ARMSTRONG, Pravin SONI
  • Publication number: 20190224162
    Abstract: The disclosure provides a method of treating pulmonary fibrosis, including idiopathic pulmonary fibrosis, in a comprising administering to the subject a pharmaceutical composition comprising from about 1% by weight to about 99% by weight of cromolyn sodium with an inhalation device.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 25, 2019
    Inventors: William GERHART, Ahmet TUTUNCU, Robert Craig ARMSTRONG, Pravin SONI
  • Publication number: 20190183846
    Abstract: Methods for the treatment of systemic mast cell related disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: February 20, 2019
    Publication date: June 20, 2019
    Inventors: William Gerhart, Pravin Soni, Ahmet Tutuncu
  • Publication number: 20190175546
    Abstract: Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders, are provided.
    Type: Application
    Filed: February 12, 2019
    Publication date: June 13, 2019
    Inventors: William Gerhart, Manfred Keller, Ahmet Tutuncu, Pravin Soni
  • Publication number: 20190175503
    Abstract: The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.
    Type: Application
    Filed: February 15, 2019
    Publication date: June 13, 2019
    Inventors: William Gerhart, Ahmet Tutuncu, Pravin Soni